CHF36.41
1.70% today
SIX Swiss Exchange, Apr 01, 05:30 pm CET
ISIN
CH1243598427
Symbol
SDZ
Index
Sector
Industry

Sandoz Stock price

CHF36.41
-3.34 8.40% 1M
+1.10 3.12% 6M
-0.76 2.04% YTD
+9.20 33.81% 1Y
+6.91 23.42% 3Y
+6.91 23.42% 5Y
+6.91 23.42% 10Y
SIX Swiss Exchange, Closing price Tue, Apr 01 2025
-0.63 1.70%
ISIN
CH1243598427
Symbol
SDZ
Index
Sector
Industry

Key metrics

Market capitalization CHF15.95b
Enterprise Value CHF19.29b
P/E (TTM) P/E ratio 5,974.19
EV/FCF (TTM) EV/FCF 87.78
EV/Sales (TTM) EV/Sales 2.11
P/S ratio (TTM) P/S ratio 1.75
P/B ratio (TTM) P/B ratio 2.16
Dividend yield 1.62%
Last dividend (FY24) CHF0.60
Revenue (TTM) Revenue CHF9.12b
EBIT (operating result TTM) EBIT CHF1.36b
Free Cash Flow (TTM) Free Cash Flow CHF219.72m
EPS (TTM) EPS CHF0.01
P/E forward 23.31
P/S forward 1.68
EV/Sales forward 2.03
Show more

Is Sandoz a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,804 stocks worldwide.

Sandoz Stock Analysis

Unlock Scores for Free

Analyst Opinions

16 Analysts have issued a Sandoz forecast:

10x Buy
63%
6x Hold
38%

Analyst Opinions

16 Analysts have issued a Sandoz forecast:

Buy
63%
Hold
38%

Financial data from Sandoz

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
9,120 9,120
-
100%
- Direct Costs 4,806 4,806
-
53%
4,313 4,313
-
47%
- Selling and Administrative Expenses 1,693 1,693
-
19%
- Research and Development Expense 821 821
-
9%
1,799 1,799
-
20%
- Depreciation and Amortization 442 442
-
5%
EBIT (Operating Income) EBIT 1,357 1,357
-
15%
Net Profit 2.67 2.67
-
0%

In millions CHF.

Don't miss a Thing! We will send you all news about Sandoz directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sandoz Stock News

marktEINBLICKE
4 months ago
Der Generikamarkt ist hart umkämpft. Aus der Schweiz ist eine Novartis-Abspaltung ein wichtiger Player, der auch eine gewisse Schlüsselrolle inne hat.

Company Profile

Sandoz Group AG engages in focusing on generic pharmaceuticals and bio similar medical products. It acquires, manages and sells investments and intellectual property in the healthcare and medical device industry and conducts all business at home and abroad. The firm can acquire, sell, debit and manage interests in other companies, intellectual property rights and real estate at home and abroad, as well as establish branches and subsidiaries at home and abroad. The company was founded on January 17, 2022 and is headquartered in Rotkreuz, Switzerland.

Head office Switzerland
CEO Richard Saynor
Employees 23,000
Founded 2022
Website www.sandoz.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today